Digestive Enzyme Market - Demand Outlook, Regional Trends & Forecast (2024-2032)

Digestive Enzyme Market Synopsis:

Digestive Enzyme Market Size Was Valued at USD 698.0 Million in 2023, and is Projected to Reach USD 1677.9 Million by 2032, Growing at a CAGR of 8.3% From 2024-2032.

Digestive enzyme industry can be defined as the segment of the food and/or the healthcare chain that deals with the production, sale, and application of enzymes involved in digestion of foods. These enzymes are playing important roles of biocatalysts that must help to hydrolyze complex macromolecules such as carbohydrates, proteins fats and fibre into simpler more bioavailable molecules. These enzymes come in a range of forms including dietary supplements, functional foods and therapeutic medications and are taken regularly by people with digestion problems as well as by ordinary citizens who want to improve their health or who consciously or unconsciously take enzymes to enable the digestion of certain food products. Due to the sales growing consciousness of health and wholesome food digestive rate enzym is turning into inevitable segment for early cautionary measures and moreover for treatment of digestive dysfunction. Some prevailing tendencies that shape the market include elevating the proportion of people aged 65 and over, the rising rate of GI tract diseases, elevating demand for natural and plant-based products, and progress in the enzyme study.

There has been rapid advancement in the digestive enzyme market in the most recent past, mainly attributed by the people’s increased consciousness about their digestive systems. Digestive enzymes are widely used regulators of metabolism, which allows effectively breaking food and absorbing nutrients. Thanks to people’s growing interest in consuming enzymes in order to enhance digestion, today’s market offers a rather wide range of enzyme products, including those developed for therapy of such diseases as lactose intolerance, IBS, and others. Moreover, the increasing incidence of obesity, poorly developed eating habits and a sedentary lifestyle has intensified the instances of the gastrointestinal disorders, the demand for digestive enzymes, as well. It is also attributed to growth in disposable income especially in the emerging market since monetary expenditure on health is progressing.

The increasing trend on the use of natural and plant derived ingredients in supplements and functional foods and beverages is another key driver to the growth of the digestive enzyme market. There is growing demand of digestive enzyme preparations of plant origin like papain from papaya, bromelain from pineapple and that derived from microbes. The increased popularity of veganism along with plant based diets has only added to the food enzyme demand which has no animal sourced assistance. Furthermore, enzyme industries are heavily investing its research and development terminus to formulate better, more stable and broader spectrum enzymes that fulfill the various needs of the economy. It is believed that these opportunities are going to provide more scope for the market in the future years.

Digestive Enzyme Market Trend Analysis:

Growing Demand for Plant-Based Digestive Enzymes

• This testifies to one of the current trends in the perspective development of the digestive enzyme market: arrising of plant-based digestive enzymes. This is driven by the recent awareness about veganism, vegetarianism, and plants based diets that are all rapidly on the rise, thus making the demand for plant derived enzyme products incredibly high. There is a shift in the consumption patterns and people are now paying more attention towards their wellbeing needs, therefore there is a trend in the market for natural, non GMO and non-cruelty free digestive aids. The plant-based enzyme sources include the papaya (papain) and pineapple (bromelain) which are preferred to the animal ones by consumers because they are presumed to be safer and renewable sources. This has been supplemented by increased concern with sustainability and ethical issues, especially amid the growing population of younger consumers. The global consumption of plant-sourced enzymes is expected to strengthen its variables in the coming years and hence is estimated to drive the market.

Expanding Therapeutic Applications

• One of the potential avenues for market growth within therapeutic applications is yet another aspect of the digestive enzyme market closely connected to the market players. This is owing to increase in the number of diagnosed cases of chronic Digestive conditions like IBS, celiac disease and IBD, that require enzyme-specific therapeutic solutions. Furthermore, enzymes are also used in other therapeutic applications learning from additional therapeutic area opportunities such as digestion disorders and overall gut health. Manufacturers and scientists are more and more interested in producing different digestive enzyme preparations for various disorders and enhanced efficiency in treatment. The increased expenditure on products in the category to develop new and targeted and effective enzyme treatments is highly conducive for the development opportunities of the digestive enzyme.

Digestive Enzyme Market Segment Analysis:

Digestive Enzyme Market Segmented on the basis of Enzyme Type, Origin, Application and region.  

By Enzyme Type, Carbohydrase segment is expected to dominate the market during the forecast period

• Carbohydrases are the enzymes which facilitate the conversion of carbohydrates into simpler sugars and they are expected to remain in leadership position in the demanded digestive-enzyme market within the forecast period. This is because carbohydrases are used to break down certain carbohydrates, and today there are more and more digestive problems such as lactose intolerance and gluten sensitivity. These enzymes are important to people with diminished complex carbohydrate breakdown and are immensely beneficial when taken in supplement form. Also, with increased consumers’ awareness of gluten and low-carb diets, it is predicted that sales of enzyme products for the digestion of carbohydrate-containing meals will experience the same increase. In the healthcare industry, carbohydrases are used in medicine to cure diseases such as IBS and improve demand for them in the market.
• Besides their anti-inflammatory properties, carbohydrases also have a major application in the food and particularly the functional food and functional beverage industries. This is so because the enzyme applies in the production of low sugar and high fiber foods products which are dominating the market. The increasing consumer knowledge of gut health and the increasing trend toward carbohydrate or functional foods and plant diets will continue to strengthen the carbohydrase segment in the forthcoming years.

By Origin, Animal segment expected to held the largest share

• Consumers have been relying on animal-derived enzymes for some time now making the segment to record a higher share in the market of digestive enzymes. Pancreatin and pepsin are two examples of animal-based enzymes that are sourced from animal pancreas, but for a long time, they have been used in the preparation of enzyme supplements consumption. They are powerful and effective in the digestion of proteins, fats, and carbohydrates, which is why used for treating diseases of the GI tract. Another factor that elaborates the process of research and development of animal-derived enzyme product is the production of stable and effective formulations that are preferably used in the healthcare circle as well as in the society.
• However, due to effectiveness and continuous demand in medical and therapeutic markets, the animal derived enzymes still dominates the market even though plant-based and microbial enzymes have gained market in recent years. These enzymes are common especially in clinical most situations where stronger digestive products are needed. Due to their high performance, the segment by the origin of the animal is anticipated to dominate the market share across the forecast period due to the widespread application in pharmaceuticals and dietary supplements.

Digestive Enzyme Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• According to the analysis, in the year 2023, the NAFTA region has the largest share in the digestive enzymes market, capturing 35 to 40% value share. In particular, the U.S. is an important driver of this dominance as there is high health care consciousness, a growing incidence of gastrointestinal diseases, and large producers of enzymes. Thus, the increasing need for takeout services and products, such as digestive enzymes, is explained by various factors that include the rising population of elderly citizens, the continuous increase in healthcare costs and the expand consumer base attracted by the concept of preventive medicine. Also, the higher penetration of plant diet and the advancing consciousness about gut health add to the region’s leadership in the global market share.

Active Key Players in the Digestive Enzyme Market:

• Alkaline Earth (USA)
• Amway (USA)
• DuPont (USA)
• Enzyme Solutions Inc. (USA)
• Enzymedica, Inc. (USA)
• Life Extension (USA)
• Lallemand Inc. (Canada)
• Novozymes A/S (Denmark)
• Origin Enterprises PLC (Ireland)
• Pall Corporation (USA)
• Prozyme Inc. (USA)
• Specialty Enzymes & Biotechnologies Co. (USA)
• Synbiotics Corporation (USA)
• Thermo Fisher Scientific Inc. (USA)
• Vitasoy International Holdings Limited (Hong Kong)
• Other Active Players